SCHEMBL10083152

SCHEMBL10083152

CN1CCN(c2ccc3nc(-c4ccc5nc(-c6cccc(-c7cccc(-c8ccc(/C=C/c9ccc(C=CI)cc9)cc8)c7)c6)[nH]c5c4)[nH]c3c2)CC1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.62
SMN1; SMN2 Q16637 4/20 0.62
TOP1 P11387 3/20 0.62
TOP2A P11388 3/20 0.62
HPGD P15428 1/20 0.62
HSD17B10 Q99714 1/20 0.62
KDM4E B2RXH2 2/20 0.62
NPC1 O15118 1/20 0.62
POLB P06746 1/20 0.62
RAB9A P51151 1/20 0.62
MEN1 O00255 2/20 0.57
MAPT P10636 2/20 0.57
BLM P54132 2/20 0.57
KMT2A Q03164 2/20 0.57
SLCO2B1 O94956 1/20 0.57
GLA P06280 1/20 0.57
RECQL P46063 1/20 0.57
BCL2L1 Q07817 1/20 0.57
SLCO1B3 Q9NPD5 1/20 0.57
TDP1 Q9NUW8 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10083153 0.89 ALDH1A1 (0.66) ALDH1A1SMN1; SMN2TOP1TOP2AHPGD
SCHEMBL14656343 0.85 ALDH1A1 (0.80) ALDH1A1SMN1; SMN2TOP1TOP2AHPGD
SCHEMBL26252728 0.83 ALDH1A1 (0.71) ALDH1A1SMN1; SMN2TOP1TOP2AHPGD
SCHEMBL14399402 0.82 ALDH1A1 (0.80) ALDH1A1SMN1; SMN2TOP1TOP2AHPGD
SCHEMBL12101904 0.81 ALDH1A1 (0.81) ALDH1A1SMN1; SMN2TOP1TOP2AHPGD
SCHEMBL26252732 0.79 ALDH1A1 (0.79) ALDH1A1SMN1; SMN2TOP1TOP2AHPGD
SCHEMBL10082670 0.79 ALDH1A1 (0.62) ALDH1A1SMN1; SMN2TOP1TOP2AHPGD
SCHEMBL25138200 0.79 ALDH1A1 (0.70) ALDH1A1SMN1; SMN2TOP1TOP2AHPGD
SCHEMBL18973765 0.78 DGAT1 (0.74) ALDH1A1SMN1; SMN2TOP1TOP2AHPGD
SCHEMBL18595033 0.78 SMN1; SMN2 (0.77) ALDH1A1SMN1; SMN2TOP1TOP2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8097238-B2 Cell targeting conjugates PETER MACCALLUM CANCER INSTITUTE (AU) 2012-01-17 US disclosed